Triple
T10214555
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Inflectra |
E242408
|
entity |
| Predicate | hasGenericName |
P23148
|
FINISHED |
| Object |
infliximab-dyyb
Infliximab-dyyb is a monoclonal antibody biosimilar to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
|
E850004
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d381ae26c48190985abd0e25ee5d04 |
elicitation | completed |
| NER | batch_69d3aa273bdc8190bc4cf67a7923cebc |
ner | completed |
| NED1 | batch_69d652ea80dc81908bc65ee2ec390467 |
ned_source_triple | completed |
| NED2 | batch_69d65835a11c819083d069ab0f644d4c |
ned_description | completed |
| NEDg | batch_69d657818b008190a24170717cff53b9 |
nedg | completed |
Created at: April 6, 2026, 11:04 a.m.